Lincoln Pharma. Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Jun-2023	Mar-2023	Dec-2022	Sep-2022	Jun-2022
Gross Sales	135.62	112.46	133.77	140.61	123.47
Excise Duty	--	--	--	--	--
Net Sales	135.62	112.46	133.77	140.61	123.47
Other Operating Income	--	--	--	--	--
Other Income	7.69	3.90	6.36	5.72	6.49
Total Income	143.31	116.36	140.12	146.33	129.97
Total Expenditure	114.90	95.82	107.02	111.71	106.56
PBIDT	28.41	20.54	33.11	34.62	23.41
Interest	0.42	1.15	0.33	0.14	0.41
PBDT	27.99	19.39	32.78	34.48	23
Depreciation	2.55	2.41	2.26	2.42	2.07
Minority Interest Before NP	--	--	--	--	--
Tax	5.51	3.40	8.47	8.18	5.94
Deferred Tax	0.92	1.01	0.44	0.16	(0.03)
Reported Profit After Tax	19.01	12.56	21.61	23.71	15.01
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	19.01	12.56	21.61	23.71	15.01
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	19.01	12.56	21.61	23.71	15.01
EPS (Unit Curr.)	9.49	6.27	10.79	11.84	7.49
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	20.03	20.03	20.03	20.03	20.23
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	20.95	18.26	24.75	24.62	18.96
PBDTM(%)	20.64	17.24	24.50	24.52	18.63
PATM(%)	14.02	11.17	16.16	16.86	12.16

QuickLinks for Lincoln Pharmaceuticals Ltd.